GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Therapeutics Co Ltd (XKRX:115450) » Definitions » Cyclically Adjusted FCF per Share

HLB Therapeutics Co (XKRX:115450) Cyclically Adjusted FCF per Share : ₩0.00 (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is HLB Therapeutics Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

HLB Therapeutics Co's adjusted free cash flow per share for the three months ended in Mar. 2024 was ₩0.000. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ₩0.00 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -0.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of HLB Therapeutics Co was -0.40% per year. The lowest was -8.70% per year. And the median was -4.55% per year.

As of today (2024-05-27), HLB Therapeutics Co's current stock price is ₩8190.00. HLB Therapeutics Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ₩0.00. HLB Therapeutics Co's Cyclically Adjusted Price-to-FCF of today is .


HLB Therapeutics Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for HLB Therapeutics Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Therapeutics Co Cyclically Adjusted FCF per Share Chart

HLB Therapeutics Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -226.44 -287.28 -341.55 -290.58 -290.31

HLB Therapeutics Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -269.70 -292.98 -310.38 -290.31 -

Competitive Comparison of HLB Therapeutics Co's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, HLB Therapeutics Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HLB Therapeutics Co's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HLB Therapeutics Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where HLB Therapeutics Co's Cyclically Adjusted Price-to-FCF falls into.



HLB Therapeutics Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, HLB Therapeutics Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0/118.8477*118.8477
=0.000

Current CPI (Mar. 2024) = 118.8477.

HLB Therapeutics Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -22.728 99.353 -27.188
201409 -12.322 99.608 -14.702
201412 -99.469 99.098 -119.293
201503 -92.378 99.720 -110.097
201506 -85.779 100.050 -101.895
201509 -49.706 100.110 -59.010
201512 -139.927 100.220 -165.935
201603 -27.507 100.560 -32.509
201606 -103.241 100.790 -121.738
201609 -49.153 101.460 -57.577
201612 -94.613 101.560 -110.718
201703 -111.143 102.850 -128.431
201706 -103.036 102.610 -119.341
201709 -200.717 103.490 -230.503
201712 -40.145 102.990 -46.326
201803 -34.610 104.100 -39.513
201806 -18.903 104.130 -21.575
201809 -244.701 105.650 -275.269
201812 181.479 104.350 206.692
201903 -61.433 104.490 -69.874
201906 -162.977 104.880 -184.682
201909 -31.559 105.200 -35.653
201912 -64.474 105.120 -72.894
202003 -61.697 105.540 -69.476
202006 -125.693 104.870 -142.446
202009 -149.101 106.200 -166.858
202012 -9.918 105.765 -11.145
202103 -6.624 107.357 -7.333
202106 -117.371 107.579 -129.666
202109 34.413 108.759 37.605
202112 -162.257 109.676 -175.825
202203 -50.662 111.806 -53.853
202206 13.711 114.083 14.284
202209 -45.721 114.831 -47.320
202212 -150.027 115.200 -154.777
202303 181.557 116.550 185.137
202306 -229.507 117.140 -232.853
202309 -104.921 119.111 -104.689
202312 136.243 118.848 136.243
202403 0.000 118.848 0.000

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


HLB Therapeutics Co  (XKRX:115450) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


HLB Therapeutics Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of HLB Therapeutics Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


HLB Therapeutics Co (XKRX:115450) Business Description

Traded in Other Exchanges
N/A
Address
22F, Parkview Tower, 6, Jeongja-Dong, Bundang-Gu, Seongnam-si, 463-863, KOR, 463-811
HLB Therapeutics Co Ltd is a bio company that pursues first-in-class and innovates new drug development. With the development and validation of new drugs for various hard-to-treat disorders, HLB Therapeutics is becoming a global biopharmaceutical company focused on alleviating patient suffering.

HLB Therapeutics Co (XKRX:115450) Headlines

No Headlines